Research Options:

Week of Expected Pricing 11/21/2023
Company Name ELEVAI LABS INC
Proposed Ticker ELAB
CUSIP 28622K104
Business Description We are a physician-dispensed skincare company with a focus on modernizing aesthetic skincare. We conduct research and development to advance innovative and science-driven topical skincare that complements the medical aesthetics industry. Upon our founding in 2020, we initiated our research and development phase for our current product formulations. Since 2022, we have principally employed a business-to-business model in which we produce and commercialize a new generation of topical skincare products that contain our proprietary stem cell-derived Elevai Exosomes™ designed to enhance the appearance of skin.
Lead Underwriter Univest Securities, LLC,Webull Financial LLC
Co-Managers N/A
Initial Shares 15,00,000
Revised Initial Shares N/A
Initial Price $4.00-$6.00
Revised Price N/A
Final Price $4.00
Final Ticker ELAB

 

 

   
  © 2024 ICE Data Services. All rights reserved.